LONDON, ONTARIO--(Marketwire - November 14, 2007) - Stellar Pharmaceuticals Inc. (“Stellar”) (TSX VENTURE: SLX)(OTCBB: SLXCF), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today reported signing a licensing agreement with Torrex Chiesi Pharma GmbH (“Torrex Chiesi”), based in Vienna, Austria in respect of the distribution and sale of NeoVisc®, a product used for the treatment of osteoarthritis, in Eastern Europe. The territory covers a number of countries, including Austria, Czech Republic, Slovakia, Croatia, Serbia, Montenegro, Macedonia, Bosnia, Herzegovina, Poland, Hungary, Russia and the Commonwealth of Independent States (“CIS”).
